Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models
Fig 7
Four PPA-containing metabolites of fosmetpantotenate detected in monkey blood after a single oral administration of 300 mg/kg.